Responses
Poster Presentations
P95 First two US patients with lupus nephritis (LN) treated with anti-CD19 chimeric antigen receptor (CAR) T-cell therapy: preliminary results from the KYSA-1 phase 1, multicenter study of KYV-101
Compose a Response to This Article
Other responses
No responses have been published for this article.